A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
21 Years
N/A
Both
Breast Cancer, Gastrointestinal Cancer
Trial Information
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
Inclusion Criteria:
- Diagnosis of primary breast cancer or gastrointestinal cancer
- Currently prescribed capecitabine
- Age 21 years or older
- Able to understand written and oral English
Exclusion Criteria:
- Major psychopathology or cognitive impairment likely in the judgment of the research
staff to interfere with the participation or completion of the protocol.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
adherence to oral chemotherapy
Outcome Description:
Participation in the study entails completion of five short questionnaires related to the medication adherence (Medication Adherence Questionnaire), beliefs about medication (Beliefs about Medications Questionnaire), side effect experience (Frequency, Intensity, and Burden of Side Effects Rating), self-efficacy (Self-efficacy for Appropriate Medication Use) and satisfaction with medication information (Satisfaction with Information about Medicines Scale) as well as a demographic and treatment data sheet.
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Pamela Ginex, EdD, RN, OCN
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
11-194
NCT ID:
NCT01487343
Start Date:
November 2011
Completion Date:
November 2013
Related Keywords:
- Breast Cancer
- Gastrointestinal Cancer
- Oral Chemotherapy
- capecitabine
- questionnaire
- breast
- gastric
- 11-194
- Breast Neoplasms
- Gastrointestinal Neoplasms
Name | Location |
|---|---|
| Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
